Authors:
KLEIN SC
BOER LH
DEWEGER RA
DEGAST GC
BAST EJEG
Citation: Sc. Klein et al., RELEASE OF CYTOKINES AND SOLUBLE CELL-SURFACE MOLECULES BY PBMC AFTERACTIVATION WITH THE BISPECIFIC ANTIBODY CD3XCD19, Scandinavian journal of immunology, 46(5), 1997, pp. 452-458
Authors:
KLEIN SC
VANDERBURG SH
BOER LH
MELIEF CJM
KAST WM
DEGAST GC
BAST EJEG
Citation: Sc. Klein et al., TARGETING OF CYTOTOXIC T-CELLS AGAINST LEUKEMIC B-CELLS BY BISPECIFICANTIBODY (ACD3 X ACD19) DOES NOT DISTRACT THE T-CELL FROM ITS PRIMARYTARGET, The Journal of immunology, 159(11), 1997, pp. 5545-5549
Authors:
VOOIJS WC
POST J
WIJDENES J
SCHUURMAN HJ
BOLOGNESI A
POLITO L
STIRPE F
BAST EJEG
DEGAST GC
Citation: Wc. Vooijs et al., EFFICACY AND TOXICITY OF PLASMA-CELL-REACTIVE MONOCLONAL-ANTIBODIES B-B2 AND B-B4 AND THEIR IMMUNOTOXINS, Cancer immunology and immunotherapy, 42(6), 1996, pp. 319-328
Authors:
VOOIJS WC
POST J
GLENNIE M
WIJDENES J
STIRPE F
BAST EJEG
DEGAST GC
Citation: Wc. Vooijs et al., IMMUNOTOXIN AND CD3 CONTAINING BISPECIFIC ANTIBODY-DIRECTED AGAINST THE SAME ANTIGEN (SYNDECAN-I) ARE EQUALLY EFFECTIVE IN-VITRO AGAINST PLASMA-CELL LINES, Blood, 88(10), 1996, pp. 3616-3616
Authors:
KLEIN SC
VANDERBURG SH
BOER LH
MELIEF CJM
KAST WM
DEGAST GC
BAST EJEG
Citation: Sc. Klein et al., TARGETING OF CYTOTOXIC T-CELLS AGAINST LEUKEMIC B-CELLS BY BISPECIFICANTIBODY (ACD3XACD19) DOES NOT DISTRACT THE T-CELL FROM ITS PRIMARY TARGET, Blood, 88(10), 1996, pp. 340-340
Authors:
KLEIN SC
HOOIJBERG E
BOER LH
HEKMAN A
DEWEGER RA
BAST EJEG
DEGAST GC
Citation: Sc. Klein et al., EFFECT OF TARGET-CELL ANTIGEN DENSITY ON THE EFFICACY OF THE BISPECIFIC ANTIBODY ACD3XACD19, Blood, 88(10), 1996, pp. 341-341
Authors:
VANHOUTEN AA
HAAGEN IA
CLARK M
GEERARS A
DELAU W
BAST EJEG
DEGAST GC
Citation: Aa. Vanhouten et al., FIRST RESULTS OF INTRAVENOUS APPLICATION OF BISPECIFIC ANTIBODY (CD3 CD19 SHR-1) TO PATIENTS WITH CD19 POSITIVE B-CELL MALIGNANCIES - A PHASE-1 STUDY/, Experimental hematology, 21(8), 1993, pp. 1120-1120
Citation: Jcc. Borleffs et al., INVITRO AND INVIVO MEASUREMENT OF CELL-MEDIATED-IMMUNITY IN PATIENTS WITH HIV-1 INFECTION, Scandinavian journal of immunology, 37(6), 1993, pp. 634-636
Authors:
VANHOUTEN AA
HAAGEN IA
CLARK M
GEERARS A
DELAU W
VROOM TM
BAST EJEG
DEGAST GC
Citation: Aa. Vanhouten et al., CYTOKINE RELEASE AFTER INTRAVENOUS ADMINISTRATION OF BISPECIFIC ANTIBODY (CD3 CD19, SHR-1) - A PHASE-I STUDY IN PATIENTS WITH CD19 POSITIVEB-CELL MALIGNANCIES/, Blood, 82(10), 1993, pp. 10000580-10000580